Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

A Phase I Study of Tomotherapy in Patients With Primary Benign and Low-grade Brain Tumors: Late Toxicity and Quality of Life.

Boychak A, Bauman G, Fisher B, Abdulkarim B, Amanie J, Fulton D, Murtha A, Patel S, Urtasun R, Ghosh S, Roa WH.

Am J Clin Oncol. 2016 Apr;39(2):160-6. doi: 10.1097/COC.0000000000000034.

PMID:
24457533
2.

High-dose radiotherapy using helical tomotherapy for vertebral metastasis: early clinical outcomes and cord dose specification.

Lee DS, Kwak YK, Jeong SM, Song JH, Kang YN, Lee SN, Jang HS, Kim YS, Yoon SC, Choi BO.

Jpn J Clin Oncol. 2013 Jun;43(6):646-53. doi: 10.1093/jjco/hyt050. Epub 2013 Apr 23.

PMID:
23613190
3.

French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patients.

Vendrely V, Henriques de Figueiredo B, Rio E, Benech J, Belhomme S, Lisbona A, Frison E, Doussau A, Nomikossoff N, Mahé MA, Kantor G, Maire JP.

Radiat Oncol. 2015 Aug 14;10:170. doi: 10.1186/s13014-015-0477-6.

4.

Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk.

Buglione M, Spiazzi L, Saiani F, Costa L, Shehi B, Lazzari B, Uccelli C, Pasinetti N, Borghetti P, Triggiani L, Donadoni L, Pedretti S, Magrini SM; Neuro-Oncology Group, Spedali Civili, Brescia University, Brescia, Italy.

Tumori. 2014 May-Jun;100(3):272-7. doi: 10.1700/1578.17200.

6.

Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy.

Miwa K, Matsuo M, Ogawa S, Shinoda J, Yokoyama K, Yamada J, Yano H, Iwama T.

Radiat Oncol. 2014 Aug 14;9:181. doi: 10.1186/1748-717X-9-181.

7.

[Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].

Liem X, Chira C, Fourquet A, Campana F, Peurien D, Fournier-Bidoz N, Kirova YM.

Cancer Radiother. 2014 Jan;18(1):15-22. doi: 10.1016/j.canrad.2013.07.149. Epub 2013 Dec 6. French.

PMID:
24316350
8.

Hypofractionated helical tomotherapy using 2.5-2.6 Gy daily fractions for localized prostate cancer.

Lopez Guerra JL, Isa N, Matute R, Russo M, Puebla F, Kim MM, Sanchez-Reyes A, Beltran C, Jaen J, Bourgier C, Marsiglia H.

Clin Transl Oncol. 2013 Apr;15(4):271-7. doi: 10.1007/s12094-012-0907-y. Epub 2012 Jul 24.

PMID:
22855189
9.

A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases.

Caravatta L, Deodato F, Ferro M, Macchia G, Massaccesi M, Cilla S, Padula GD, Mignogna S, Tambaro R, Carrozza F, Flocco M, Cantore G, Scapati A, Buwenge M, Sticca G, Valentini V, Cellini N, Morganti AG.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):e463-8. doi: 10.1016/j.ijrobp.2012.06.023. Epub 2012 Aug 18.

PMID:
22909415
10.

Intensity-modulated radiotherapy for nasopharyngeal carcinoma: improvement of the therapeutic ratio with helical tomotherapy vs segmental multileaf collimator-based techniques.

Chen AM, Yang CC, Marsano J, Liu T, Purdy JA.

Br J Radiol. 2012 Aug;85(1016):e537-43. doi: 10.1259/bjr/23807619. Epub 2012 Jan 17.

11.

Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.

Deville C, Both S, Hwang WT, Tochner Z, Vapiwala N.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):763-72. doi: 10.1016/j.ijrobp.2009.08.043. Epub 2010 Feb 18.

PMID:
20171807
12.

Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experience.

Fonteyne V, Sadeghi S, Ost P, Vanpachtenbeke F, Vuye P, Lumen N, De Meerleer G.

Acta Oncol. 2015 Jun;54(6):854-61. doi: 10.3109/0284186X.2014.974826. Epub 2014 Nov 11.

PMID:
25387271
13.

Whole brain helical Tomotherapy with integrated boost for brain metastases in patients with malignant melanoma-a randomized trial.

Hauswald H, Habl G, Krug D, Kehle D, Combs SE, Bermejo JL, Debus J, Sterzing F.

Radiat Oncol. 2013 Oct 10;8:234. doi: 10.1186/1748-717X-8-234.

14.

Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.

Han K, Cummings BJ, Lindsay P, Skliarenko J, Craig T, Le LW, Brierley J, Wong R, Dinniwell R, Bayley AJ, Dawson LA, Ringash J, Krzyzanowska MK, Moore MJ, Chen EX, Easson AM, Kassam Z, Cho C, Kim J.

Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):587-94. doi: 10.1016/j.ijrobp.2014.06.061. Epub 2014 Sep 3.

PMID:
25194664
15.

Prospective phase II study of tomotherapy based chemoradiation treatment for locally advanced anal cancer.

Joseph K, Nijjar Y, Warkentin H, Schiller D, Tankel K, Usmani N, Severin D, Ghosh S, Syme A, Nijjar T, Mulder K, Doll C, Wong C, Field C.

Radiother Oncol. 2015 Nov;117(2):234-9. doi: 10.1016/j.radonc.2015.08.008. Epub 2015 Aug 22.

PMID:
26306677
16.

Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases.

Chow E, Davis L, Holden L, Tsao M, Danjoux C.

J Pain Symptom Manage. 2005 Jul;30(1):18-23.

PMID:
16043003
17.

Analysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomas.

Tang JM, Ma XM, Hou YL, Dai LY, Cao HB, Ye M, Bai YR.

J Radiat Res. 2014 Jul;55(4):794-802. doi: 10.1093/jrr/rru012. Epub 2014 Mar 9.

18.

Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.

Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1440-50.

PMID:
15590175
19.

Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer.

Zhou L, Liu J, Xue J, Xu Y, Gong Y, Deng L, Wang S, Zhong R, Ding Z, Lu Y.

Radiat Oncol. 2014 May 21;9:117. doi: 10.1186/1748-717X-9-117.

20.

The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.

Sultanem K, Patrocinio H, Lambert C, Corns R, Leblanc R, Parker W, Shenouda G, Souhami L.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):247-52.

PMID:
14697445

Supplemental Content

Support Center